Joe Daccache, Ph.D.’s Post

𝗖𝗲𝗹𝗹 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗖𝗗𝗠𝗢 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟭.𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 The research report provides an overview of the Cell Therapy CDMO industry chain's development, evaluating the market status for Commercial (Stem Cell, Non-Stem Cell) and Academic Research (Stem Cell, Non-Stem Cell) segments in both developed and developing markets. The report examines key enterprises and analyzes cutting-edge technology, patents, hot applications, and market trends within the Cell Therapy CDMO sector. Regionally, North America and Europe exhibit steady growth fueled by government initiatives and heightened consumer awareness. In contrast, Asia-Pacific, spearheaded by China, leads the global Cell Therapy CDMO market, driven by robust domestic demand, supportive policies, and a robust manufacturing base. The market is categorized by Type and Application, and the forecast for the period 2024-2031 details growth among segments, providing accurate calculations and forecasts for consumption value by Type and Application in terms of value. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝗰𝗼𝗽𝗲 𝗮𝗻𝗱 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗖𝗲𝗹𝗹 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗖𝗗𝗠𝗢 𝗠𝗮𝗿𝗸𝗲𝘁.𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/dvFpvqnu *𝗕𝘆 𝗧𝘆𝗽𝗲: Stem Cell, Non-Stem Cell *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Commercial, Academic Research, Others *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Charles River Laboratories, The Discovery, BioCentriq, FUJIFILM Diosynth Biotechnologies, Exothera , WuXi AppTec, Pharmaron, Ontario Bioscience Innovation Organization (OBIO), Cell Therapies Pty Ltd, AGC Biologics, Cytiva, Helixmith, ThermoGenesis Holdings, Inc., ANEMOCYTE , Thermo Fisher Scientific, CBMM, Bio Elpida, Genezen, CCRM, RoslinCT, GenScript ProBio #celltherapy #cdmo #biotechindustry #lifesciences #researchanddevelopment #biotechnology #commercialresearch #academicresearch #technologyinnovation #marketanalysis #globalmarkets #innovativetechnology #healthcareindustry #bioprocessing #regenerativemedicine #cellmanufacturing #clinicalresearch #biomedical #industryinsights #businessgrowth #celltherapymarket

⚡𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐍𝐨𝐭𝐞: Utility of the CGX10 Cell Isolation System in Closed CAR-T Cell Therapy Manufacturing - via Sony Biotechnology Inc. CAR-T therapy is a revolutionary technology that can modify a patient’s immune system, offering great potential as a novel therapeutic. Manufacturing these treatments requires the isolation of a rare population of T-cells, and minimizing contamination with other subtypes presents a key challenge. Sony Biotechnology recently conducted a study to investigate the potential of the CGX10 Cell Isolation System to isolate naïve T-cells using multiparametric selection. This cell isolation technology was easily integrated into a closed CAR-T manufacturing process, and successfully sorted rare cell populations using multiple immunological markers. More about 𝐂𝐆𝐗𝟏𝟎 𝐂𝐞𝐥𝐥 𝐈𝐬𝐨𝐥𝐚𝐭𝐢𝐨𝐧 𝐒𝐲𝐬𝐭𝐞𝐦 👉 https://lnkd.in/dqFgMtzv #FlowCytometry #Biotechnology #CGX10

In Situ Hybridization Market Size, Share & Trends Analysis Report By Technology (Fluorescent In Situ Hybridization (FISH), Chromogenic In Situ Hybridization (CISH)), By Probe (DNA, RNA), By Product (Instruments, Kits & Probes, Software, Services), By Application (Cancer, Cytogenetics, Developmental Biology, Infectious Diseases, Others), By End-use (Hospitals & Diagnostic Laboratories, CROs, Academic& Research Institutes, Others) , COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028 📚 𝐆𝐞𝐭 𝐭𝐡𝐢𝐬 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 👇https://lnkd.in/dBZR2Nx7 📚 𝐓𝐨𝐩 𝐌𝐨𝐫𝐞 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐀𝐫𝐞:- 👇 Roche Flagship Biosciences, Inc. Genemed Biotechnologies, Inc. Genentech Genetics Associates, Inc. Histalim Indica Labs Intimex Group KREATECH Diagnostics Lanterne Dx Leica Biosystems Merck Group Merck KGaA, Darmstadt, Germany Molecular Pathology Laboratory Network, Inc. (MPLN) NeoGenomics Laboratories Novus Biologicals LLC OpGen, Inc. PanPath B.V. Partolab PerkinElmer PT. Biozatix Indonesia QIAGEN Reveal Biosciences Sakura Finetek USA Scytek Laboratories Thermo Fisher Scientific Ventana Medical Systems Vyant Bio Zytomed Systems GmbH Abbott abcam Abnova Advanced Cell Diagnostics AdvanDx Affymetrix Agilent Technologies Asuragen

Rat Model Market Size, Share & Trends Analysis Report By Rat Type (Inbred, Outbred, Knockout, Hybrid, Others), By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer, Others), By Application (Research & Development, Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases, Others (Production and Quality Control, Academics, Others), By Use (Human, Veterinary), By End-use (Companies, Pharmaceutical, Biotechnology, Cosmetics, Others (Organizations, Government, Non-government , Academic and Research Institutes, Contract Research Organizations (CRO)), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2031 IMIR Market Research Pvt. Ltd. Don't miss out on this opportunity to stay informed about the latest trends in the Industry.   📚𝐆𝐞𝐭 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐀𝐭 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭𝐞𝐝 𝐏𝐫𝐢𝐜𝐞:📝👇https://lnkd.in/dVyUnJiS 📚𝐑𝐞𝐩𝐨𝐫𝐭 𝐅𝐨𝐜𝐮𝐬𝐞𝐝 𝐎𝐧 𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬: Applied StemCell Aragen Life Sciences Vitalstatistix Biocytogen Biomere (Biomedical Research Models, Inc.) Biomere Champions Oncology, Inc. Charles River Laboratories Covance Crown Bioscience Cyagen GemPharmatech genOway HARBOUR BIOMED Harlan Laboratories, Inc. Hera BioLabs Horizon Discovery ingenious targeting laboratory Inotiv JANVIER LABS Labcorp Oncodesign Precision Medicine - OPM Ozgene PerkinElmer Horizon Pharmatest Services Regenera Pharma Taconic Biosciences The Jackson Laboratory TransCure bioServices Transposagen Biopharmaceuticals TransViragen, Inc. Vivo Bio Tech Ltd. #RatModel #Intellectualmarketinsightresearch👤 #Marketresearchreports #Size  #Share #Trends #Growth #Opportunity #Outlook #Forecast #Covid19 #Segments #KeyPlayers #RegionsOutlook #GrowthPotential #PriceTrends #CompetitiveMarket #Forecast 

Factors such as increasing funding for cell-based research, are driving the market growth at a faster pace. The incidence of chronic and infectious diseases is on the rise, which is driving the demand for new therapies, including cell-based therapies that require cell isolation technologies. The development of new and advanced cell isolation technologies, such as microfluidics-based cell sorting, magnetic-activated cell sorting, and fluorescence-activated cell sorting, is driving the growth of the market. Governments and private organizations are investing heavily in life sciences and biotechnology research, which is driving the demand for cell isolation products and technologies. Companies identified as key players in the market include Agilent Technologies, Akadeum Life Sciences, Inc., Alfa Laval, BD, Bio-Rad Laboratories, Bio-Techne, Corning Incorporated, Danaher Corporation, Invent Biotechnologies, Lonza, MagBio Genomics Inc., MiCareo, Inc., Miltenyi Biotec, PerkinElmer, Inc., pluriSelect Life Science UG (haftungsbeschränkt) & Co.KG, Promega Corporation , Proteintech Group, QIAGEN, Sartorius, STEMCELL Technologies, Terumo Medical Corporation and Thermo Fisher Scientific #cellisolation #biotech #celltherapy #biotechnology

[Symposium] On behalf of the Organizing Committee, we are excited to announce the confirmed speakers to date for Biologics by Design 2023. This is a free in-person only symposium focusing on computational design and engineering of macromolecular therapeutics. The event will be held on Sep 20, at the Merck Research Labs in S San Francisco. For more information, visit https://bit.ly/3s9oSvQ We are 𝗮𝗰𝗰𝗲𝗽𝘁𝗶𝗻𝗴 𝗽𝗼𝘀𝘁𝗲𝗿 abstracts (deadline Sep 10). Those interested should submit their abstracts for consideration when registering. 𝗖𝗢𝗡𝗙𝗜𝗥𝗠𝗘𝗗 𝗦𝗣𝗘𝗔𝗞𝗘𝗥𝗦 - Philippe Archambault, Chemical Computing Group 𝘚𝘵𝘳𝘶𝘤𝘵𝘶𝘳𝘦-𝘉𝘢𝘴𝘦𝘥 𝘊𝘩𝘢𝘳𝘨𝘦 𝘊𝘢𝘭𝘤𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘧𝘰𝘳 𝘗𝘳𝘦𝘥𝘪𝘤𝘵𝘪𝘯𝘨 𝘗𝘳𝘰𝘱𝘦𝘳𝘵𝘪𝘦𝘴 𝘢𝘯𝘥 𝘗𝘳𝘰𝘧𝘪𝘭𝘪𝘯𝘨 𝘈𝘯𝘵𝘪𝘣𝘰𝘥𝘺 𝘛𝘩𝘦𝘳𝘢𝘱𝘦𝘶𝘵𝘪𝘤𝘴 - Fernando Garces, formerly of Gilead Sciences 𝘕𝘦𝘹𝘵 𝘎𝘦𝘯𝘦𝘳𝘢𝘵𝘪𝘰𝘯 𝘰𝘧 𝘔𝘶𝘭𝘵𝘪𝘴𝘱𝘦𝘤𝘪𝘧𝘪𝘤 𝘈𝘯𝘵𝘪𝘣𝘰𝘥𝘺 𝘌𝘯𝘨𝘪𝘯𝘦𝘦𝘳𝘪𝘯𝘨 - Possu Huang, Stanford University 𝘈𝘯 𝘈𝘭𝘭-𝘈𝘵𝘰𝘮 𝘗𝘳𝘰𝘵𝘦𝘪𝘯 𝘎𝘦𝘯𝘦𝘳𝘢𝘵𝘪𝘷𝘦 𝘔𝘰𝘥𝘦𝘭 - Saeed Izadi, Genentech 𝘋𝘦𝘤𝘪𝘱𝘩𝘦𝘳𝘪𝘯𝘨 𝘋𝘦𝘢𝘮𝘪𝘥𝘢𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘐𝘴𝘰𝘮𝘦𝘳𝘪𝘻𝘢𝘵𝘪𝘰𝘯 𝘪𝘯 𝘛𝘩𝘦𝘳𝘢𝘱𝘦𝘶𝘵𝘪𝘤 𝘗𝘳𝘰𝘵𝘦𝘪𝘯𝘴: 𝘌𝘧𝘧𝘦𝘤𝘵 𝘰𝘧 𝘕𝘦𝘪𝘨𝘩𝘣𝘰𝘳𝘪𝘯𝘨 𝘙𝘦𝘴𝘪𝘥𝘶𝘦 - Zachary Rollins, Merck Research Labs 𝘈𝘣𝘔𝘦𝘭𝘵: 𝘓𝘦𝘢𝘳𝘯𝘪𝘯𝘨 𝘈𝘯𝘵𝘪𝘣𝘰𝘥𝘺 𝘛𝘩𝘦𝘳𝘮𝘰𝘴𝘵𝘢𝘣𝘪𝘭𝘪𝘵𝘺 𝘧𝘳𝘰𝘮 𝘔𝘰𝘭𝘦𝘤𝘶𝘭𝘢𝘳 𝘋𝘺𝘯𝘢𝘮𝘪𝘤𝘴 - Sreyoshi Sur, Moderna Inc.  𝘐𝘰𝘯𝘪𝘻𝘢𝘣𝘭𝘦 𝘈𝘮𝘪𝘯𝘰 𝘓𝘪𝘱𝘪𝘥𝘴 𝘋𝘪𝘴𝘵𝘳𝘪𝘣𝘶𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘌𝘧𝘧𝘦𝘤𝘵𝘴 𝘰𝘯 𝘋𝘚𝘗𝘊/𝘤𝘩𝘰𝘭𝘦𝘴𝘵𝘦𝘳𝘰𝘭 𝘔𝘦𝘮𝘣𝘳𝘢𝘯𝘦𝘴: 𝘐𝘮𝘱𝘭𝘪𝘤𝘢𝘵𝘪𝘰𝘯𝘴 𝘧𝘰𝘳 𝘓𝘪𝘱𝘪𝘥 𝘕𝘢𝘯𝘰𝘱𝘢𝘳𝘵𝘪𝘤𝘭𝘦 𝘚𝘵𝘳𝘶𝘤𝘵𝘶𝘳𝘦 𝗣𝗥𝗘𝗟𝗜𝗠𝗜𝗡𝗔𝗥𝗬 𝗔𝗚𝗘𝗡𝗗𝗔 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 𝑃𝑅𝐸-𝑆𝑌𝑀𝑃𝑂𝑆𝐼𝑈𝑀 𝑊𝑂𝑅𝐾𝑆𝐻𝑂𝑃𝑆 (𝐸𝑚𝑏𝑎𝑠𝑠𝑦 𝑆𝑢𝑖𝑡𝑒𝑠) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 08:00 Morning Coffee / Registration (check-in/badge pick-up) 08:30 Analyzing Antibody-Antigen Complexes and Property Predictions 10:00 Morning Break 10:30 Antibody Homology Modeling and Structural Bioinformatics 12:00 Workshop Lunch - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 𝑆𝐶𝐼𝐸𝑁𝑇𝐼𝐹𝐼𝐶 𝑃𝑅𝐸𝑆𝐸𝑁𝑇𝐴𝑇𝐼𝑂𝑁𝑆 (𝑀𝑒𝑟𝑐𝑘 𝑅𝑒𝑠𝑒𝑎𝑟𝑐𝘩 𝐿𝑎𝑏𝑠) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 12:30 Registration (check-in/badge pick-up) 13:30 Opening Remarks 13:40 Scientific Presentations 15:40 Afternoon Break - Poster Viewing 16:10 Scientific Presentations 18:10 Closing Remarks 18:20 Social Hour with Posters 𝗢𝗥𝗚𝗔𝗡𝗜𝗭𝗘𝗥𝗦 Essam Metwally, Merck Research Labs Raul Alvarez, Chemical Computing Group 𝗟𝗢𝗖𝗔𝗧𝗜𝗢𝗡 - AM: Pre-symposium Workshops Embassy Suites, 250 Gateway Blvd., SSF - PM: Scientific Presentations, Posters & Social Hour Merck Research Laboratories, 213 E Grand Ave., SSF #DrugDiscovery #DrugDesign #Biologics #AntibodyModeling #ProteinEngineering